drugset / Trial / NCT06947941
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate KarXT + KarX-EC as a treatment for psychosis associated with Alzheimer's disease.
Timeline
- Start
- 2026-03-25
- Primary completion
- 2028-02-21
- Completion
- 2028-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KarX-EC | Unknown | — | — |
| Subject | Trospium | Small molecule | — | — |